ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

American Home Products Changes Name To Wyeth.

March 1, 2002

Outside Experts Might Lengthen NDA Approval, Peck Asserts

September 7, 1990

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014

Human Genome Project publishes its final product.

October 22, 2004

ASCO To Begin Large Study On Quality Of Cancer Care.

January 28, 2000

In Brief: Levine Leaves NIH For Pittsburgh; Fischbach Leaves Harvard For NIH; NCI Researcher Dies

June 12, 1998